SEC 13F Intelligence

Managers / Q4 2025 · view latest →

Vazirani Asset Management LLC

CIK 0001716476 · 1540 BROADWAY, SUITE 1600, NEW YORK, NY, 10036 · 646-504-4181

Reported Value
$16M
Q4 2025
Positions
10
Filings on Record
18
2019–present window
Filed
Feb 17, 2026
original filing

Summary

Vazirani Asset Management LLC reported $16M in U.S.-listed holdings across 10 positions for Q4 2025.

The portfolio is heavily concentrated: NSC alone accounts for 26.3% of reported value.

Compared with Q3 2025, the fund opened 8 new positions and exited 11.

Portfolio Metrics

Turnover
+48.7%
vs prior filed quarter
Top-10 Concentration
+100.0%
share of reported value
Largest Position
+26.3%
Norfolk Southn
New / Exited
8 / 11
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’21: $87MQ4 ’21Q1 ’22: $116MQ2 ’22: $77MQ3 ’22: $93MQ3 ’22Q4 ’22: $59MQ1 ’23: $53MQ2 ’23: $59MQ2 ’23Q3 ’23: $65MQ4 ’23: $24MQ1 ’24: $36MQ1 ’24Q2 ’24: $47MQ3 ’24: $56MQ4 ’24: $32MQ4 ’24Q1 ’25: $27MQ2 ’25: $26MQ3 ’25: $28MQ3 ’25Q4 ’25: $16MQ1 ’26: $43Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 97.9%Other: 2.1%
  • Common Stock · 97.9% · $16M
  • Other · 2.1% · $354,000

Quarter-over-Quarter Changes full breakdown →

vs Q3 2025 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
DAYDAYFORCE INCNEW+50.0K50.0K+$3M$3M
EXKEXACT SCIENCES CORPNEW+25.0K25.0K+$3M$3M
CONFLUENT INCNEW+59.9K59.9K+$2M$2M
WBDWARNER BROS DISCOVERY INCNEW+30.0K30.0K+$864,600$864,600
CDTXCIDARA THERAPEUTICS INCNEW+2.5K2.5K+$552,225$552,225
AMICUS THERAPEUTICS INCNEW+25.0K25.0K+$356,000$356,000
ANYWHERE REAL ESTATE INCNEW+25.0K25.0K+$354,000$354,000
KEZAR LIFE SCIENCES INCNEW+48.4K48.4K+$304,612$304,612

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q4 2025

10 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1NSCNORFOLK SOUTHN CORPhistory →COM26.29%$4M15.0K
2DAYDAYFORCE INChistory →COM20.99%$3M50.0K
3EXKEXACT SCIENCES CORPhistory →COM15.41%$3M25.0K
4FYBRFRONTIER COMMUNICATIONS PAREhistory →COM11.55%$2M50.0K
5CONFLUENT INCCLASS A COM11.00%$2M59.9K
6WBDWARNER BROS DISCOVERY INChistory →COM SER A5.25%$864,60030.0K
7CDTXCIDARA THERAPEUTICS INChistory →COM NEW3.35%$552,2252.5K
8AMICUS THERAPEUTICS INCCOM2.16%$356,00025.0K
9ANYWHERE REAL ESTATE INCCOM2.15%$354,00025.0K
10KEZAR LIFE SCIENCES INCCOM NEW1.85%$304,61248.4K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$43M20May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$16M10Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$28M13Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$26M17Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$27M15May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$32M19Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$56M29Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$47M25Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$36M18May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$24M22Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$65M26Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$59M28Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$53M17May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$59M24Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$93M37Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$77M30Aug 12, 202213F-HRchanges · EDGAR ↗
Q1 2022$116M57May 5, 202213F-HRchanges · EDGAR ↗
Q4 2021$87M51Feb 3, 202213F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.